You are here
FDA Issues Public Health Advisory on the Fentanyl Patch
The FDA is conducting an investigation into the deaths associated with these patches. The Agency has been examining the circumstances of product use to determine if the reported adverse events may be related to inappropriate use of the patch or factors related to the quality of the product. It is possible that some patients and their health care providers may not be completely aware of the dangers of these potent narcotic drug products and the important recommendations regarding their safe use.
The Agency is working closely with the manufacturers of fentanyl patches to fully evaluate the risks associated with their use and to develop a plan to help patients avoid accidental fentanyl overdose.
For more information, go to: https://www.fda.gov/cder/drug/infopage/fentanyl/default.htm.
Source: The Food and Drug Administration